Need Help? Call 1­-866-­796-­7386
« back to stock screener

  KERX stock: Keryx Biopharmaceuticals

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$3.36
Market Cap
304.1M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
-
P/S
3.85
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-98.4K
FCF
-0.8
Op. Margin
-94.10%
Net Margin
-96.40%
ROE
257.50%
ROI
-90.50%
ROA
-60.90%
EPS Growth
49.50%
Current Ratio
3.1
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
InfuSystem Holdings Inc (INFU) $3.50 - - 66.6M Strong Buy
Champions Oncology Inc (CSBR) $10.16 - - 137.7M Strong Buy
DENTSPLY SIRONA Inc (XRAY) $38.12 - 0.90% 8.23B Strong Buy
Quorum Health Corp (QHC) $3.75 - - 132.7M Strong Buy
Integer Holdings Corp (ITGR) $85.76 - - 2.79B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More